Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.24 (Beat by $0.0065) |
EPS GAAP Actual | $0.24 (Beat by $0.0065) |
Revenue Actual | $2.272B |
Revenue Surprise | Beat by $2272M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.13907 |
EPS GAAP Estimate | $1.13907 |
Revenue Estimate | $3.086514829B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 8.51 | 14.93 | 8.05342 | 8.89897 | 4 |
Dec 2028 | 8.1525 | 15.59 | 7.56538 | 8.50924 | 9 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.25 | -0.11899 | 2.272B | 5.72% | -92.32M |
FQ4 2024 (Dec 2024) | 0.73 | 0.73 | 2.48B | 10.56% | 2480M |
FQ3 2024 (Sep 2024) | 2.17 | 2.17 | 3.732B | 8.98% | 3732M |
FQ3 2019 (Sep 2019) | 1.03 | 1.03 | 1.64576B | 100% | 1645.76M |
FQ2 2024 (Jun 2024) | 0.87 | 0.87 | 2.748B | 9.61% | 2748M |
FQ1 2024 (Mar 2024) | 0.41 | 0.41 | 2.142B | 15.13% | 2142M |
FQ4 2023 (Dec 2023) | -0.55 | -0.55 | 2.218B | 100% | 2218M |
FQ3 2023 (Sep 2023) | 6.83 | 6.83 | 3.397B | 15.09% | 3397M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.13907
Consensus Revenue Estimates
3.086514829B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.02689 | -- | 2.91401 | 3.18806 | 13 |
FQ2 2027 (Jun 2027) | 1.16784 | -- | 1.12429 | 1.23002 | 8 |
FQ1 2027 (Mar 2027) | 0.3898 | -- | 0.37526 | 0.41056 | 8 |
FQ4 2026 (Oct 2026) | 3.38381 | -- | 3.30701 | 3.5592 | 9 |
FQ3 2026 (Jul 2026) | 1.31794 | -- | 1.28803 | 1.38625 | 9 |
FQ2 2026 (Jun 2026) | 1.30465 | -- | 1.20627 | 1.38108 | 12 |
FQ1 2026 (Mar 2026) | 0.4566 | 45.25 | 0.42217 | 0.48335 | 7 |
FQ4 2025 (Oct 2025) | 2.83201 | 74.22 | 2.76774 | 2.9788 | 10 |
FQ3 2025 (Jul 2025) | 1.07545 | -101.78 | 1.05104 | 1.13119 | 10 |
FQ2 2025 (Jun 2025) | 1.13907 | 23.62 | 1.05318 | 1.2058 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.95B | -- | 4.81B | 5.15B | 10 |
FQ2 2027 (Jun 2027) | 3.63B | -- | 3.53B | 3.78B | 10 |
FQ1 2027 (Mar 2027) | 2.79B | -- | 2.71B | 2.91B | 10 |
FQ4 2026 (Oct 2026) | 4.72B | -- | 4.64B | 4.91B | 11 |
FQ3 2026 (Jul 2026) | 3.38B | -- | 3.32B | 3.51B | 16 |
FQ2 2026 (Jun 2026) | 3.4B | -- | 3.2B | 3.55B | 10 |
FQ1 2026 (Mar 2026) | 2.57B | 11.76 | 2.43B | 2.69B | 10 |
FQ4 2025 (Oct 2025) | 4.27B | 41.93 | 4.2B | 4.44B | 17 |
FQ3 2025 (Jul 2025) | 3.04B | -22.69 | 2.99B | 3.16B | 10 |
FQ2 2025 (Jun 2025) | 3.09B | 10.97 | 2.91B | 3.23B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.36899 | 0.25 | -0.11899 | -47.6% |
FQ4 2024 (Dec 2024) | 0.73 | 0.73 | 100% | |
FQ3 2024 (Sep 2024) | 2.17 | 2.17 | 100% | |
FQ3 2019 (Sep 2019) | 1.03 | 1.03 | 100% | |
FQ2 2024 (Jun 2024) | 0.87 | 0.87 | 100% | |
FQ1 2024 (Mar 2024) | 0.41 | 0.41 | 100% | |
FQ4 2023 (Dec 2023) | -0.55 | -0.55 | 100% | |
FQ3 2023 (Sep 2023) | 6.83 | 6.83 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.36B | $2.27B | $-92.32M | -4.06% |
FQ4 2024 (Dec 2024) | $0B | $2.48B | $2480M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.73B | $3732M | 100% |
FQ3 2019 (Sep 2019) | $0B | $1.65B | $1645.76M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.75B | $2748M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.14B | $2142M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.22B | $2218M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.4B | $3397M | 100% |